2,4-pyridinedicarboxylic acid and Prostatic Neoplasms

2,4-pyridinedicarboxylic acid has been researched along with Prostatic Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, CC; Chen, TJ; Cheng, HH; Chu, CH; Hsu, KC; Hung, CL; Kung, HJ; Li, LT; Liu, R; Wang, LY; Wang, SM; Wang, WC; Wu, CM; Yang, JM	1

Other Studies

1 other study(ies) available for 2,4-pyridinedicarboxylic acid and Prostatic Neoplasms

Article	Year
KDM4B as a target for prostate cancer: structural analysis and selective inhibition by a novel inhibitor. Journal of medicinal chemistry, 2014, Jul-24, Volume: 57, Issue:14 Topics: Apoptosis; Cell Proliferation; Crystallography, X-Ray; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Jumonji Domain-Containing Histone Demethylases; Kinetics; Male; Models, Molecular; Molecular Targeted Therapy; Prostatic Neoplasms; Stilbenes; Structure-Activity Relationship; Tumor Cells, Cultured	2014

Article

Year

KDM4B as a target for prostate cancer: structural analysis and selective inhibition by a novel inhibitor.

Journal of medicinal chemistry, 2014, Jul-24, Volume: 57, Issue:14

Topics: Apoptosis; Cell Proliferation; Crystallography, X-Ray; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Jumonji Domain-Containing Histone Demethylases; Kinetics; Male; Models, Molecular; Molecular Targeted Therapy; Prostatic Neoplasms; Stilbenes; Structure-Activity Relationship; Tumor Cells, Cultured

2014